Submit Manuscript  

Article Details

Effects of Galantamine in Alzheimers Disease: Double-blind Withdrawal Studies Evaluating Sustained Versus Interrupted Treatment

[ Vol. 8 , Issue. 7 ]


M. Gaudig, U. Richarz, J. Han, B. Van Baelen and B. Schauble   Pages 771 - 780 ( 10 )


Alzheimer's disease, clinical trial, dementia, galantamine, randomized withdrawal, treatment, galantamine discontinuation, ADAS-cog/11 score, CIBIC-plus evaluation


Janssen EMEA Medical Affairs, Beerse, Belgium.

Read Full-Text article